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Discussion of aortic valve replacement has primarily concerned the choice 
between tissue and mechanical prostheses. Less emphasis has been placed 
on prosthesis ize. Despite technical advances increasing prosthesis orifice 
area, small valves implanted in the unenlarged aortic root may not be 
significantly less obstructive than the stenotic native valves they replace. 
Methods: In this work we studied 52 patients (31 women, 21 men; mean age 
59.2 years) in whom valve prostheses ized 19, 21, 23, or 25 mm (30 
bioprostheses and 22 tilting disc valves) had been implanted to replace 
stenotic aortic valves. Most patients with 19 or 21 mm prostheses were 
women. Doppler and conventional echocardiographic studies were per- 
formed in the 10 days preceding the operation and between 10 and 40 
months (mean 18 months) after the operation. The patients receiving larger 
valve sizes had significantly larger body surface areas than those receiving 
smaller valve sizes (mainly women). Results: No significant differences were 
observed between preoperative and postoperative diameters or left ventric- 
ular systolic function parameters, but left ventricular mass and mass index 
decreased in all four groups (albeit nonsignificantly in the 19 mm group, 
and with less statistical significance in the 21 mm group than in the 23 and 
25 mm groups). Postoperative peak and mean transvalvular p essure drops 
were significantly greater in the 19 mm group than in the other groups, and 
the 21 mm group had significantly greater transvalvular pressure drops 
than the 25 mm group. Postoperative effective valve area was significantly 
smaller in the 19 mm group than in the 21 mm group, and significantly 
smaller in the 21 mm group than in the 23 and 25 mm groups. Conclusion: 
We conclude that despite undeniable recent improvements in the design of 
artificial heart valves, 19 mm aortic prostheses continue to create signifi- 
cant obstruction of the left ventricular outflow tract and, possibly as a 
consequence of this, fail to bring about significant reduction in left 
ventricular hypertrophy. (J Thorac Cardiovasc Surg 1996;112:273-80) 
I n general, replacing severely dysfunctional aortic valves improves performance and prognosis. The 
surgical management of patients with small aortic 
rings is nevertheless controversial because of the 
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suboptimal hemodynamics of small sizes of even the 
most advanced types of prostheses; prognosis is 
worse for patients with small implanted valves than 
for those with larger prostheses? -5 
For patients having a small aortic ring, the usual 
alternative to small valve implantation is to reduce 
valve prosthesis-patient mismatch by implanting a 
larger valve after enlargement of the aortic ring. The 
drawback of this approach is that it increases the 
duration and, in principle, the risk of the opera- 
tion.4, 6, 7 Another alternative might be the use of 
valvular homografts, which have excellent hemody- 
namics but which are not readily available to most 
centers,  
Aortic valve stenosis nduces left ventricular by- 
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Table I. Intralaboratory variability of Doppler 
echocardiographic parameters in the prostheses and 
bioprostheses included in the study 
Percent 
Left ventricular outflow tract diameter 4 
Peak velocity 8 
Mean gradient 11 
Effective orifice area 10 
pertrophy (LVH) as an adaptive response to the 
chronic overload caused by the valve disease. LVH 
is the causal link between aortic valve stenosis and 
myocardiac ischemia, diastolic and systolic ventric- 
ular dysfunction, and ventricular arrhythmias asso- 
ciated with sudden death. A number of studies, 
mostly of patients with systemic arterial hyperten- 
sion, have confirmed the adverse influence of LVH 
on life expectancy 9' 10; among patients with aortic 
valve prostheses implanted to redress aortic steno- 
sis, those with echocardiographically detected LVH 
have a significantly higher postoperative death rate 
than those without. 11 After aortic valve replacement 
to reduce the obstruction to ejection, left ventricular 
mass (LVM) tends to decrease; this decrease may 
reduce the risk of ischemia, dysfunction, and elec- 
trical instability and in any case is known to be 
associated with improved cardiac performance and 
prognosis. 
Doppler echocardiography is currently the stan- 
dard technique for noninvasive valuation of the 
structure and function of heart valve prostheses. 
Measurements of mean and peak transvalvular p es- 
sure drops, effective valve area, and cardiac output 
obtained by Doppler echocardiography correlate 
satisfactorily with those obtained by invasive meth- 
ods.8, !2-14 
We report here the results of a retrospective study 
of the hemodynamics of various designs and sizes of 
aortic valve prosthesis and their relationship to 
postimplantation reduction in LVH. 
Patients and methods 
Protocol. Between January 1989 and December 1994, 
68 patients in our center underwent replacement of the 
aortic valve alone on account of predominantly aortic 
valvular stenosis. None of these patients underwent, or 
had previously undergone, a cardiovascular operation 
of any other kind. Thirty-seven other patients who were 
operated on for severe aortic stenosis in the same 
period were excluded from the study because they also 
had other types of cardiac disease: 18 had moderate or 
severe aortic insufficiency, 11 mitral valve disease, 5 
coronary artery disease, 2 aortic insufficiency and cor- 
onary artery disease, and 1 mitral valve disease and 
coronary artery disease. The follow-up protocol of all 
68 patients with "pure" aortic stenosis included evalu- 
ation of valve function by Doppler echocardiography. 
We studied retrospectively 52 of these patients who 
fulfilled the following criteria: (1) before the operation 
they had sinus rhythm and greater stenosis of a native 
aortic valve than of any other valve, and they had no 
other cardiac disease; (2) the operation consisted only 
in the implantation of an aortic valve prosthesis, with no 
aortic ring enlargement procedure; (3) a Doppler echo- 
cardiogram good enough for evaluation of left ventric- 
ular structure and function and aortic valve disease had 
been taken within the 10 days preceding the operation; 
and (4) 12 months or more after valve implantation the 
patients were in New York Heart Association (NYHA) 
functional classes I or II. 
Of the 52 patients tudied, 12 received 19 mm valves: 2 
MitroFlow pericardial bioprostheses (MitroFlow Interna- 
tional Inc., Richmond, Canada), 6 Labcor-Santiago peri- 
cardial bioprostheses (Labcor Laboratories, Belo Hori- 
zonte, Brazil), and 4 CarboMedics bileaflet prostheses 
(CarboMedics Inc., Austin, Tex.); 15 received 21 mm 
valves (1 MitroFlow pericardial bioprosthesis, 7 Labcor- 
Santiago bioprostheses, and 7 CarboMedics valves); 16 
received 23 mm valves (9 Labcor-Santiago bioprostheses 
and 7 CarboMedics valves); and 9 received 25 mm valves 
(5 Labcor-Santiago bioprostheses and 4 CarboMedics 
valves). All patients continued to have sinus rhythm 
during postoperative follow-up. Follow-up echocardio- 
graphic studies took place 10 to 40 months after the 
operations (mean 18 months). 
Of the 16 patients with "pure" aortic stenosis not 
included in the study, only two had 19 mm valve prosthe- 
ses. One of these, who was in NYHA class III, died 
suddenly 33 days after the operation and the other was 
excluded from the study because of atrial fibrillation 
before the operation. One year after the operation, no 
patient with a 19 mm prosthesis was in NYHA class III or 
IV. 
Echoeardiography. Echocardiograms were performed 
with a Hewlett-Packard Sonos 1000 apparatus (Hewlett- 
Packard Co., Palo Alto, Calif.) with 3.5 MHz transducers 
for images and 2.5 MHz transducers for Doppler effect 
measurements. All echocardiograms were recorded on 
SuperVHS videotape (Panasonic, Matsushita Electric 
Works, Osaka, Japan) for subsequent analysis. 
M-mode measurements. M-mode echocardiograms 
were taken for measurement (in millimeters) of teledias- 
tolic interventricular septum thickness (IVST), left ven- 
tricular posterior wall thickness (PWT), and telediastolic 
(LVEDD) and telesystolic (LVESD) left ventricular di- 
ameters; simultaneous two-dimensional longitudinal or 
transverse parasternal views were used to ensure that the 
measurements were taken immediately above the papil- 
lary muscles. All measurements were repeated for four to 
six successive heartbeats, and the values accepted for each 
patient were the means of these four to six values. 
LVM was calculated from Devereux and Reichek's 
formulal5: LVM (in grams) = 1.04 × ([LVEDD + IVST 
+ PWT]) 3 - LVEDD 3) - 13.6. 
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Table II. Preoperative clinical and echocardiographic data 
Valve size (no. of patients) 
19 mm (12) 21 mm (15) 23 mm (16) 25 mm (9) 
Age (yr) 65.1 -- 6.4 59.7 _+ 8.1 53.3 _+ il.4 58.8 +- 12.6 
Body surface area (m z) 1.57 -+ 0.12 !.64 -+ 0.11 1.71 +- 0.18 1.78 _+ 0.17 
Gender (M/F) 3/9 5/10 8/8 5/4 
NYHA class (I/II/I!I/IV) 0/2/8/2 0/3/10/2 0/6/8/2 0/2/7/0 
PSG (mm Hg) 108 _+ 36 94 _+ 32 96 +- 45 93 + 42 
MSG (mm Hg) 62 -+ 23 55 _+ 20 51 _+ 28 48 + 26 
EOA (cm 2) 0.54 + 0.12 0.63 _+ 0.09 0.61 -+ 0.12 0.58 _+ 0.13 
Fractional fiber shortening (%) 33 -- 5 34 _+ 4 30 -+ 6 30 +_ 5 
Ejection fraction (%) 64 + 7 67 +_ 6 61 + 9 60 _+ 9 
Systolic blood pressure (ram Hg) 128 + 12 121 -- 14 130 + 14 122 _+ 11 
Diastolic blood pressure (mm Hg) 72 -+ 7 68 + 8 75 -+ 8 69 + 6 
Heart rate (beats/rain) 84 _+ 14 79 + 12 76 -+ 11 77 + 10 
Age: 19 mm versus; 23 mm, p < 0.01; body surface area: 19 mm versus 23 mm,p < 0.05; 19 mm versus 25 mm, p < 0.01. NYHA, New York Heart Association; 
PSG, peak flow velocity; MSG, modified flow velocity; EOA, effective orifice area. 
LVM index (LVMI, in grams per square meter) was 
defined as LVM/BSA, where BSA is body surface area in 
square meters. Left ventricular f actional shortening (per- 
cent) was calculated as 100 × (LVEDD - LVESD)/ 
LVEDD. Left ventricular ejection fraction (percent) was 
calculated as 100 × (LVEDD 3 - LVESD3)/LVEDD 3. 
Doppler effect measurements. With the guidance of 
color flow images, systolic velocities in the outflow tract 
near the valve were measured in pulsed Doppler mode 
from the apical four-chamber view. Velocities through 
native and prosthetic aortic valves were measured in the 
continuous Doppler mode from apical, suprasternal, and 
right parasternal views; once the view giving the greatest 
velocities had been found, the velocities measured from 
this view during three cardiac ycles with durations close 
to the patienfs mean beat-to-beat interval were averaged 
to yield a single value for that patient. Pulsed Doppler 
mode was used to search for increased velocities within 
the left ventricle by stepping the sample volume from the 
apex to the valve. 
Peak and mean systolic transvalvular pressure drops 
calculated from peak and mean flow velocities by the 
modified Bernoulli equation are in this article denoted 
PSG and MSG, respectively. PSGc denotes peak pressure 
drops calculated by means of the Bernoulli equation with 
correction for prevalvular velocities: PSGc = 4(Vvalv 2 - 
Vlvol2), where Vvalv is the peak velocity through the 
prosthesis and Vlvot the peak velocity in the left ventric- 
ular outflow tract just below the prosthesis. 16The area (A) 
of the left ventricular outflow tract was calculated as 
p(D/2) 2, where D was the mean diameter of the tract in 
three successive images recorded at the beginning of 
systole from the longitudinal parasternal direction. Car- 
diac output (CO) was calculated as A × VTIlvot × HR, 
where HR is heart rate and VTIlvot is the time integral of 
the velocity in the left ventricular outflow tract. 17 Cardiac 
index was calculated as CO/BSA. Effective valve areas 
were calculated by means of both the standard continuity 
equation (VAstan = SV/VTIvalv, where SV is stroke 
volume and VTIvalv the time integra ! of the velocity 
through the valve) and the simplified equation (VAsimp 
= A × Vlvot/Vvalv). is' 19 The effective area index, a 
measure of how well the flow area of the valve matches 
body size, was calculated as VAstan/BSA. 
Intralaboratory variability. To test intralaboratory 
variability in measurements of peak and mean gradients 
and effective valve areas, we repeated eterminations of 
pulsed and continuous wave parameters and of left ven- 
tricular outflow tract diameter in 21 patients within 1 
month of the postoperative echoeardiographic examina- 
tion. Variability was expressed as mean percent error. 
percent error being calculated as the absolute difference 
between the two observations divided by the mean of the 
two and expressed as a percentage (Table I). 
Statistical analysis. Results are expressed as means 
standard deviations. One-way analysis of variance was 
used to evaluate the significance of differences in mea- 
surements among valve sizes; if the F value was significant. 
the Tukey multiple comparison test was performed to 
assess differences between individual groups. Correlations 
between valve size and echocardiographic parameters 
were calculated by linear or second-degree polynomial 
regression analysis (or both) where appropriate. The 
significance of differences in the same group was esti- 
mated by means of Friedman's test. A probability (p) 
value less than 0.05 was considered statistically significant. 
Results 
Tables II and I I I  list preoperative characteristics 
of the four groups of patients defined by the size of 
the aortic prosthesis implanted. The patients in the 
larger valve size groups had significantly arger body 
surface areas than those in the smaller valve size 
groups, and they were approximately equally distrib- 
uted between the sexes, whereas most patients re- 
ceiving 19 or 21 mm prostheses were women. There 
were no statistically significant differences among 
the size groups as regards heart rate, blood pressure, 
degree of stenosis, or overall eft ventricular systolic 
function. LVM and LVMI  were significantly smaller 
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Table I I I. Preoperative and postoperative echocardiographic data (preoperative values in parentheses) 
Valve size (no. of patients) 
19 turn (12) 21 mm (15) 23 rnm (16) 25 mm (9) 
LVEDD (mm) (40.2 ± 5.8) (41.0 ± 5.3) (43.2 _+ 6.1) (44.6 - 5.3) 
40.5 ± 4.8 40.8 -+ 5.1 42.8 ± 5.2 43.9 ± 4.9 
IVST (ram) (14.5 -+ 2.5) (15.3 ± 2.8) (15.1 _+ 2.7) (14.8 ± 2.4) 
13.5 ± 2.6 12.8 _+ 2.3? 12.2 ± 2.1? 12.0 ± 1.9t 
PWT (ram) (13.7 _+ 2.1) (14.2 ± 2.5) (14.6 ± 2.3) (14.1 ± 2.1) 
12.7 ± 1.8" 12.7 ± 2.1" 11.8 _+ 2.0t 11.7 ± 2.0t 
LVM (gin) (240.5 ± 49) (279.2 _+ 56) (303.1 ± 61) (306.1 ± 52) 
224.2 ± 41 217.5 _+ 43? 214.2 _+ 45? 218.7 ± 425 
LVMI (r/m 2) (151.6 _+ 35) (170.2 _+ 49) (176.5 ± 50) (171.8 ± 41) 
137.8 _+ 30 132.7 ± 31t 124.8 ± 32* 124,6 + 305 
FS (%) (33 ± 5) (34 ± 4) (30 _+ 6) (30 ± 5) 
32 ± 5 34 ± 5 31 _+ 8 30 2 7 
EF (%) (64 ± 7) (67 ± 6) (61 _+ 9) (60 + 9) 
65±8 67_+9 63±14 61±11 
Time after operation (mo) 18 ± 11 20 _+ 10 16 _+ 12 18 --+ 10 
LVEDD, Left ventricular end-diastolic diameter; IVST, interventricular septum thickness; PW/;, left ventricular posterior wall thickness; FS, left ventricular 
fractional shortening; EF, left ventricular ejection fraction. 
*p < 0.05 (postoperative versus preoperative values). 
tp < 0.01 (postoperative verus preoperative values). 
:~p < 0.001 (postoperative versus preoperative values). 
Table IV. Ultrasonic hemodynamic data of different sizes of prosthetic heart valve in aortic position 
(mean +- SD) 
Valve size (ram) 
19 (n = 12) 21 (n  = 15) 23 (n = 16) 25 (n = 9) F p Value 
PSG (mm Hg) 30.5 -+ 10 21.4 ± 11 16.5 - 8 16.4 ± 7 6.56 0.017 
PSGc (mm Hg) 25.8 _+ 9 18.8 + 10 15.1 + 6 14.9 _+ 6 6.11 0.021 
MSG (mm Hg) 18.3 -- 7 14.2 _+ 6 9.1 + 5 8.7 _+ 4 4.98 0.039 
Stroke volume (ml) 58.7 _+ 13.1 65.7 _+ 17.3 68.2 + 11.9 83.5 ± 12.8 3.1 0.05 
Cardiac index (L/min/per 2.58 ± 0.67 2.60 ± 0.56 2.71 + 0.64 2.59 _+ 0.59 1.53 0.25 
square meter) 
VAstan (cm 2) 1.25 ± 0.12 1.48 ± 0.13 1.80 _ 0,24 2.09 _+ 0.28 18.7 <0.001 
VAsimp (cm 2) 1.18 _+ 0.14 1.43 ± 0.14 1.78 ± 0.22 1.86 ± 0.20 19.6 <0.001 
Effective area index 0.79 ± 0.11 0.89 ± 0.09 1.04 ± 0.23 1,17 ± 0.16 10.5 <0.001 
PSG, Peak transvalvular pressure drop; PSGc, peak transvalvular pressure drop corrected for prevalvular velocity; MSG, mean transvalvular pressure drop; 
VAsimp, VAstan, valve areas calculated by means of the simplified and standard continuity equations. 
in the 19 mm group than in any of the others, but the 
latter did not differ significantly one from another. 
Table III compares preoperative and postopera- 
tive echocardiographic parameters for each valve 
size group. There were no significant changes in 
diameters or in left ventricular systolic function 
parameters, but LVM and LVMI decreased in all 
four groups (albeit nonsignificantly in the 19 mm 
group and with less statistical significance in the 21 
mm group than in the 23 and 25 mm groups). In no 
prosthesis size group was there a significant differ- 
ence between patients with mechanical prostheses 
and patients with bioprostheses as regards either 
preoperative or postoperative LVM. 
In 45 of the 52 prostheses (86.5%), the greatest 
velocities were recorded from apical views. The 
greatest subvalvular velocity measured after the 
operation was 1.65 m/sec. There was a significant 
negative correlation between subvalvular diameter 
and outflow tract velocity (r = -0 .65,p  < 0.001; n = 
52). Postoperative peak and mean transvalvular 
pressure drops were significantly greater in the 19 
mm group than in the other groups. The 21 and 23 
mm groups did not differ significantly in this respect, 
and neither did the 23 and 25 mm groups, but 
transvalvular pressure drops in the 21 mm group 
were significantly greater than those in the 25 mm 
group (Table IV and Fig. 1). There were significant 
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Fig. 1. Plots of mean ± standard eviation peak (upper panel) and mean (lower panel) transvalvular 
pressure drops against aortic valve prosthesis size. Only statistically significant comparisons are i dicated. 
negative correlations between valve size and peak 
and mean transvalvular pressure drops (r = -0.64 
and r = -0.72, respectively; p < 0.001 in both 
cases). 
The prosthetic valve areas calculated from the 
simplified continuity equation correlated well with 
those given by the standard equation (VAsimp = 
0.92 × VAstan + 0.12; r = 0.91, standard error of 
the estimate = 0.07). Postoperative effective valve 
area was significantly smaller in the 19 mm group 
than in the 21 mm group and significantly smaller in 
the 21 mm group than in the 23 and 25 mm groups, 
but there was no statistically significant difference 
between the latter two groups (Table IV and Fig. 2). 
There was good linear correlation between effective 
valve area and nominal valve size (r = 0.90, p < 
0.001), and analysis of variance showed the four size 
groups to be better differentiated by effective valve 
area (F = 18.7 for VAstan, F = 19.6 for VAsimp; 
p < 0.001 in both cases) than by PSG (F = 6.56, 
p = 0.017) or MSG (F = 4.98, p = 0.039); but the 
effective area index also increased with valve size 
(r = 0.85, p < 0.001), showing valve prosthesis- 
patient mismatch. In no prosthesis ize group was 
there a significant difference between patients with 
mechanical prostheses and patients with bioprosthe- 
ses as regards valve hemodynamics (PSG, MSG, or 
effective valve area). 
Pandiastolic regurgitation was observed in apical 
continuous Doppler records in all 32 patients with 
mechanical prostheses and in 16 (53%) of those with 
bioprostheses (14 with Labcor-Santiago valves and 2 
with MitroFlow valves). Peak regurgitation velocity 
was in all cases less than 1.7 m/sec, and it was 
significantly less for the bioprostheses than for the 
mechanical prostheses, 0.6 +_ 0.3 m/sec as against 
1.3 _+ 0.3 m/sec (p < 0.01). Leakage penetrated 1 to 
3 cm into the ventricle and was deemed slight or 
negligible. Color flow echocardiograms from apical 
(two- or four-chamber views) or long-axis paraster- 
nal views showed regurgitation jets in all 38 of these 
patients. The mechanical valves exhibited two lat- 
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Fig. 2. Plot of mean _+ standard eviation effective valve area against aortic valve prosthesis ize. Only 
statistically significant comparisons are indicated. 
eral jets and a minor central jet, except one which, 
like 8 of the 16 regurgitating bioprostheses, had a 
larger central jet and no lateral jets. Aortic regurgi- 
tation was uniformly distributed among the various 
valve sizes. 
Discussion 
Doppler echocardiography is currently the most 
widely used technique for clinical evaluation of 
artificial heart valves; estimates of functional param- 
eters obtained through Doppler echocardiographic 
measurements correlate well with those obtained by 
invasive methods, 8' 12, 13 which can no longer be 
justified for the evaluation of normally functioning 
valves. Measurements obtained by the two kinds of 
technique are nevertheless not directly comparable; 
transvalvular pressure drop values determined by 
Doppler echocardiography are greater than those 
determined by invasive procedures. 1' 2o For exam- 
ple, Ihlen and coworkers 2° reported that echocar- 
diographically measured mean pressure drops 
across CarboMedics prostheses in the aortic posi- 
tion exceeded those measured with catheters by 
4.4 _+ 4.8 mm Hg. The reason for this difference 
appears to be that in clinical studies catheter tips are 
usually located more than 2 cm from the plane 
where pressure recovery occurs: in an in vitro study 
of the St Jude Medical valve 21 (St. Jude Medical, 
Inc., St. Paul, Minn.), echocardiographically mea- 
sured pressure drops agreed fully with catheter 
measurements taken at valve level but were 10.3 _+ 
2.5 mm Hg greater than catheter measurements 
taken 3 cm from the valve. 
Although aortic transvalvular pressure drops are 
influenced by transvalvular flow rate, which should 
be taken into account in evaluating their clinical 
significance, they probably depend most on the 
diameter of the valve ring, increasing with decreas- 
ing ring size. In this study there was a significant 
negative correlation between valve size and peak 
and mean transvalvular pressure drops. 
In a recent study, we TM found no significant dif- 
ference between the hemodynamic performance of 
19 mm pericardial bioprostheses and that of 19 mm 
bileaflet mechanical prostheses in the aortic posi- 
tion; as in other studies of the hemodynamics of
small prostheses, 1' 22,22-24 in which effective valve 
areas of 0.9 to 1.2 cm 2 and mean PSGs as high as 40 
mm Hg have been observed, transvalvular p essure 
drops and effective valve areas were far from satis- 
factory. These findings, together with recent reports 
that patients with small (19 or 21 ram) prostheses 
have a poorer prognosis than those with larger 
prostheses, 25 must be taken into account when 
planning operations for patients for whom aortic 
valve replacement is indicated. 
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In patients with aortic stenosis, left ventricular 
pressure is chronically elevated. LVH occurs as an 
adaptive response and, initially, keeps left ventricu- 
lar stress (the force generated by each unit of 
myocardium) within the normal range. Hypertrophy 
can be quantitated by echocardiography. In rela- 
tively symmetric ventricles, without left ventricular 
aneurysm or diastolic shape abnormality caused by 
marked dilation of the right side of the heart 
(conditions hared by all the patients in this study), 
this can be done by means of measurements ob- 
tained in the: M modelS: echocardiographic esti- 
mates of LVM calculated from Devereux and 
Reichek's formula correlate well with angiographic 
estimates of LVM, with postmortem left ventricular 
weight, and with estimates obtained by applying 
Simpson's rule or an area-length formula to two- 
dimensional echocardiographic measurements. 
New imaging techniques, such as nuclear mag- 
netic resonance imaging and ultrafast computed 
tomography, provide images of the beating heart 
with high temporal and spatial resolution allowing 
more precise calculation of volumes and LVM, 
but echocardiography is still the most cost-effi- 
cient method. 
The treatment of aortic stenosis by valve replace- 
ment is usually followed by the reduction of LVH by 
an amount variously reported as being between 16% 
and 44%. 26-29. Most regression occurs during the first 
6 months after the operation. However, most studies 
of this phenomenon have involved patients with 
valves of size.. 21 mm or more; the available infor- 
mation on patients with 19 mm valves is scant. Sire 
and associates, 3° in a retrospective study of 39 of 714 
patients in whom aortic valve prostheses of size 19, 
21, or 23 mm had been implanted (accompanied by 
aortic ring enlargement in 168 cases), found that 
patients with a 19 mm aortic prosthesis and no other 
prostheses exhibited no significant reduction in 
LVM a mean of 26 months after the operation, 
whereas those with 21 or 23 mm prostheses did 
exhibit regression, and to similar extents. However, 
inasmuch as the 10 patients with 19 mm prostheses 
had preoperative LVMIs of 129 + 47 gm/m 2 (i.e., 
only slightly above normal, despite their having 
mean aortic pressure drops and valve areas sugges- 
tive of severe aortic stenosis), whereas the 21 and 23 
mm groups had preoperative LVMIs of 150 gm/m 2 
or more, Sire and coworkers 3° suggested that the 
surgeons in their institution might have chosen to 
implant 19 mm valves only in patients with no more 
than slight LVH. Certainly, the scant ventricular 
hypertrophy of Sim's 19 mm group, and the small 
size of the study (39 patients) in relation to the 714 
patients in whom aortic valves had been implanted, 
oblige one to treat their findings with some reserve. 
Nevertheless, in our study we also found significant 
postoperative r duction in LVM in patients with 21 
to 25 mm aortic prostheses but not in patients with 
19 mm prostheses (despite the postoperative effec- 
tive valve areas of the latter group having been, as in 
the study by Sim and associates, almost double their 
preoperative areas); although the 19 mm group had 
less severe LVH than the other groups, their preop- 
erative LVMIs were far above the upper limit of the 
normal range (possibly because almost all the pa- 
tients in this group were women). 
The lack of a significant reduction in LVM in our 19 
mm group may have been due to a number of factors: 
(1) regression of LVH being slower in these patients 
than in the recipients of larger valves (although all the 
patients with 19 mm prostheses had their follow-up 
examination more than 10 months after their opera- 
tions); (2) this group being older than the others (age 
is an independent determinant ofLVM31); and (3) the 
suboptimal hemodynamics of 19 mm prostheses atrest 
and during exercise. We are currently evaluating he- 
modynamics during exercise as part of a longer-term 
(3- to 5-year) study of patients with aortic valve 
prostheses implanted to replace stenotic native vanes. 
The failure of small aortic prostheses to reduce LVM 
may be related to the results of several studies howing 
their recipients to have a poorer prognosis than recip- 
ients of larger valves. 
We conclude that despite undeniable recent im- 
provements in the design of artificial heart valves, 19 
mm aortic prostheses continue to create a significant 
obstruction of the left ventricular outflow tract and, 
possibly as a consequence of this, fail to bring about 
significant reduction in LVH. Aortic prostheses of 
this size should probably not be implanted in young 
or physically active patients or in patients with body 
surface areas greater than 1.7 m 2. Instead, aortic 
valve replacement in these groups of patients hould 
probably be effected by means of a homograft or by 
implantation of a 21 mm or larger valve after aortic 
root enlargement. 
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